Vascular Patches Market Size, Share, and Industry Analysis, By Material (Biologic and Synthetic), By Procedure (Carotid Endarterectomy, Vascular Bypass Surgery, Peripheral Arterial Repair/Reconstruction, and Others), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast,2026-2034

The vascular patches market size was valued at USD 468.8 million in 2025 and is expected to reach a market valuation of USD 503.4 million in 2026. Furthermore, the market is projected to reach a market valuation of USD 889.3 million by 2034, exhibiting a CAGR of 7.4% during the forecast period.

The global vascular patches market is experiencing significant growth due to the high prevalence of peripheral vascular diseases and the increasing number of surgeons opting for patches in various procedures over primary closure. Furthermore, the growth is also supported by innovation in biological materials, which is expected to improve outcomes.

Vascular Patches Market Driver

Rising Vascular Surgery Volumes to Fuel the Market Growth

In recent years, there has been an increasing vascular surgical volume, driven by the geriatric populations and persistent atherosclerotic disease burden. Moreover, patch angioplasty is frequently used in carotid and peripheral vascular reconstruction to reduce restenosis-related complications. As a result, companies are expanding their portfolio of vascular patches, which is expected to drive the market growth.

• For instance, according to data from the Cleveland Clinic in February 2024, nearly half of people aged 45 to 84 in the U.S. had atherosclerosis.

Download Free sample to learn more about this report.

• According to data published by the International Journal of Cardiology Congenital Heart Disease in September 2025, CHD affects around 1.0% of births, amounting to approximately 40,000 cases each year in the U.S.

Vascular Patches Market Restraint

Complications and Regulatory Burden to Restrict the Market Growth

Despite its higher use, the vascular patch is clinically sensitive, posing a risk of bleeding, infection, calcification, and restenosis, which can deter some hospitals from adopting it. Also, the stringent device regulations and post-market surveillance add substantial time and cost. This is expected to limit the expansion of indications and new launches by key players, leading to a product shortage. Such a scenario is expected to hinder market expansion.

Vascular Patches Market Opportunity

Emerging Markets and Collaborations to Offer Lucrative Growth Opportunity

In recent years, there has been an increasing focus on healthcare expansion in developing countries such as India, Brazil, China, and others. Following this, there has been an expansion of vascular surgery capacity in these countries, creating significant opportunities for key players to expand their product offerings. Additionally, several key players are strengthening their agreements to expand product offerings in both developed and developing countries, thereby increasing product availability.

• For instance, in April 2023, LeMaitre signed a 3-year exclusive U.S. distribution deal with Aziyo Biologics for its cardiovascular patches, including ProxiCor, VasCure, and Tyke.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Diseases, by Key Countries/Region, 2025
• Overview of Regulatory Scenario
• Key Industry Developments - (Partnerships, Mergers, and Acquisitions, etc.)

Analysis by Material

Based on the material, the market is segmented into biologic and synthetic.

The biologic segment is expected to hold a major share of the global market. The segment’s growth is attributed to surgeons' higher preference for bovine pericardium and ECM-derived materials due to their uniformity, strength, and ease of suturing, which facilitates precise closure in various procedures. For instance, in January 2026, the XenoSure Biologic Patch by LeMaitre is being used for precise closure during endarterectomy and vascular reconstruction.

Analysis by Procedure

In terms of procedure, the market is segmented into carotid endarterectomy, vascular bypass surgery, peripheral arterial repair/reconstruction, and others.

The carotid endarterectomy segment is expected to hold the major share of the global market during the forecast period. The segment’s growth is attributed to the higher volume of carotid endarterectomy surgery worldwide. Patch angioplasty is often preferred in these procedures due to its significant outcomes compared to primary repair. In response, companies are expanding their product offerings for such procedures.

• For instance, according to data from the Annals of Vascular Surgery in January 2023, carotid endarterectomy (CEA) ranks among the most frequently performed vascular surgeries, with over 150,000 procedures conducted globally each year, including approximately 45,000 in the U.S. alone.

Analysis by End-user

Based on end-user, the market is segmented into hospitals & ASCs, specialty clinics, and others.

The hospitals & ASCs segment is expected to hold the largest share of the global market during the forecast period. The utilization of vascular patches is more concentrated in these settings due to the significant volume of vascular procedures performed there. Additionally, other factors, such as a higher number of ASCs, favorable reimbursements in hospitals for vascular procedures, and the availability of expertise, are expected to increase the use of vascular patches in these settings.

• For instance, according to data from the Ambulatory Surgery Center Association as of March 2025, there were more than 6,500 Medicare-certified ASCs in the U.S.

Regional Analysis

Request for Customization   to gain extensive market insights.

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for the largest share, 42.3%, of the global vascular patches market in 2025. The region's growth is attributed to its well-established healthcare infrastructure and the significant presence of key players in the U.S. and Canada, which favors the high availability and utilization of vascular patches in these countries.

Asia Pacific is expected to grow at the highest CAGR during the forecast period. Countries such as India, China, and South Korea are expanding hospital capacity and improving access to vascular interventions due to a significant number of cases of atherosclerosis, driven by a high proportion of aging populations. Such a scenario is projected to increase the utilization of vascular patches in the region.

• For instance, according to the data from Press Information Bureau (PIB) in October 2025, around 12.0% of India’s population comprises aged people, and this proportion is projected to rise to 319.0 million by 2050.

Key Players Covered

The global vascular patches market is fragmented, with several major players offering a diversified portfolio of advanced products and focusing on geographic expansions to strengthen their foothold in the market.

The report includes the profiles of the following key players:

• L. Gore & Associates, Inc. (U.S.)
• LeMaitre (U.S.)
• Baxter (U.S.)
• Getinge (Sweden)
• GenScript (China)
• Braun SE (Germany)
• Edwards Lifesciences (U.S.)
• BD (U.S.)
• Cook (U.S.)
• Labcor Laboratórios Ltda. (Brazil)

Key Industry Developments

• May 2024: Teijin, Fukui Tateami, and Osaka Medical and Pharmaceutical University announced plans to launch SYNFOLIUM, a novel cardiovascular surgical patch for the treatment of congenital heart disease in Japan.
• July 2023: Osaka Medical and Pharmaceutical University, Fukui Tateami, and Teijin announced that SYNFOLIUM (OFT-G1), a novel cardiovascular surgical patch, had received approval for manufacturing and marketing in Japan.